Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-08 Exercise | 2026-04-10 5:40 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 4,316 | $0 | 533,624 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 5:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 133 | $213.32 | 533,624 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 5:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 101 | $194.47 | 533,624 (Direct) | View |
| 2026-04-08 Exercise | 2026-04-10 5:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 98 | $159.03 | 533,624 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 5:26 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 4,433 | $0 | 537,940 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 5:26 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 133 | $213.32 | 537,940 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 5:26 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 110 | $194.47 | 537,940 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 5:26 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 98 | $159.03 | 537,940 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 8:14 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 444,912 | $0 | 51,641,269 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 8:13 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 95,264 | $0 | 318,370 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 8:13 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Lai President, Global Head of R&D | 167,635 | $0 | 2,221,024 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 8:12 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 247,546 | $0 | 1,232,889 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 8:11 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Rosenberg Aaron Chief Financial Officer | 119,587 | $0 | 334,919 (Direct) | View |
| 2026-02-04 Exercise | 2026-02-06 4:57 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 21,580 | $0 | 447,109 (Direct) | View |
| 2026-02-04 Exercise | 2026-02-06 4:57 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 662 | $213.32 | 447,109 (Direct) | View |
| 2026-02-04 Exercise | 2026-02-06 4:57 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 502 | $194.47 | 447,109 (Direct) | View |
| 2026-02-04 Exercise | 2026-02-06 4:57 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 496 | $159.03 | 447,109 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 5:15 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 8,632 | $0 | 468,689 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 5:15 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 266 | $213.32 | 468,689 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 5:15 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 202 | $194.47 | 468,689 (Direct) | View |
| 2026-01-07 Exercise | 2026-01-09 5:15 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 196 | $159.03 | 468,689 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:12 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Lai President, Global Head of R&D | 427,895 | $0 | 2,053,389 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:56 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 8,632 | $0 | 735,852 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 266 | $213.32 | 735,852 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 202 | $194.47 | 735,852 (Direct) | View |
| 2025-12-10 Exercise | 2025-12-12 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 196 | $159.03 | 735,852 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:57 pm | N/A 2034-06-04 | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 34,151 | $0 | 57,226 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:57 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 2,627 | $159.03 | 57,226 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 5:28 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 12,948 | $0 | 485,953 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 5:28 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 398 | $213.32 | 485,953 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 5:28 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 302 | $194.47 | 485,953 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 5:28 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 296 | $159.03 | 485,953 (Direct) | View |
| 2025-11-11 Gift | 2025-11-13 5:06 pm | N/A N/A | BeOne Medicines Ltd. | ONC | OYLER JOHN Chief Executive Officer | 1,009,853 | $0 | 52,496,357 (Direct) | View |
| 2025-11-07 Gift | 2025-11-12 4:47 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 424,073 | $0 | 9,560,814 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 124,267 | $0 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 8,961 | $213.32 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 302 | $194.47 | 498,901 (Direct) | View |
| 2025-10-08 Exercise | 2025-10-10 4:56 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 296 | $159.03 | 498,901 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 115,622 | $0 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 1,796 | $213.32 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 6,802 | $194.47 | 637,624 (Direct) | View |
| 2025-09-10 Exercise | 2025-09-12 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 296 | $159.03 | 637,624 (Direct) | View |
| 2025-09-09 Gift | 2025-09-11 5:12 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wang Xiaodong Chair, Scientific Advisory Brd | 148,096 | $0 | 9,984,887 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-09 5:31 pm | N/A 2032-06-21 | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 34,645 | $0 | 57,226 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-09 5:31 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Sanders Corazon (Corsee) D. Director | 2,665 | $155.68 | 57,226 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A 2030-06-16 | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 1,167,322 | $0 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 22,773 | $174.43 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 57,841 | $155.68 | 2,622,329 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-15 4:40 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Wu Xiaobin President and COO | 9,180 | $159.03 | 2,622,329 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A 2032-08-04 | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 106,990 | $0 | 518,752 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 4,381 | $194.47 | 518,752 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 4:38 pm | N/A N/A | BeOne Medicines Ltd. | ONC | Lee Chan Henry SVP, General Counsel | 3,849 | $159.03 | 518,752 (Direct) | View |